Study of the novel anti-cancer mechanisms of thalidomide and HMG-CoA reductase inhibitors
博士 === 國立臺灣大學 === 藥理學研究所 === 97 === The novel anticancer mechanisms of thalidomide and HMG-CoA reductase inhibitors (statins) were investigated in this study. Thalidomide has been reported to have anti-angiogenic and anti-metastatic effects. Intercellular adhesion molecule-1 (ICAM-1) was demonstrate...
Main Authors: | Yi-Chu Lin, 林意筑 |
---|---|
Other Authors: | 陳青周 |
Format: | Others |
Language: | en_US |
Published: |
2008
|
Online Access: | http://ndltd.ncl.edu.tw/handle/80677314201820769171 |
Similar Items
-
Pleiotropic effects of the HMG-CoA reductase inhibitors
by: Mihos CG, et al.
Published: (2011-04-01) -
The discovery and development of HMG-CoA reductase inhibitors.
by: A Endo
Published: (1992-11-01) -
Butyrate and HMG-CoA reductase inhibitors in ulcerative colitis
by: McKay, Damian
Published: (2010) -
HMG-CoA reductase kinase: measurement of activity by methods that preclude interference by inhibitors of HMG-CoA reductase activity or by mevalonate kinase.
by: H J Harwood, Jr, et al.
Published: (1982-07-01) -
MTD–CoMSIA modelling of HMG-CoA reductase inhibitors
by: DANIEL M. DUDA-SEIMAN, et al.
Published: (2011-01-01)